Citadel Advisors’s CASTLIGHT HEALTH, INC. CSLT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-10,900
| Closed | -$17K | – | 15241 |
|
|
2021
Q4 | $17K | Buy |
10,900
+100
| +0.9% | +$165 | ﹤0.01% | 13614 |
|
|
2021
Q3 | $17K | Sell |
10,800
-12,600
| -54% | -$24.7K | ﹤0.01% | 13661 |
|
|
2021
Q2 | $62K | Buy |
23,400
+6,500
| +38% | +$12.1K | ﹤0.01% | 13238 |
|
|
2021
Q1 | $26K | Buy |
+16,900
| New | +$29.3K | ﹤0.01% | 13054 |
|
|
2020
Q3 | – | Sell |
-18,000
| Closed | -$15K | – | 11025 |
|
|
2020
Q2 | $15K | Buy |
+18,000
| New | +$13.4K | ﹤0.01% | 9599 |
|
|
2018
Q4 | – | Sell |
-12,700
| Closed | -$34K | – | 10026 |
|
|
2018
Q3 | $34K | Buy |
+12,700
| New | +$44.9K | ﹤0.01% | 8897 |
|
|
2016
Q1 | – | Sell |
-7,600
| Closed | -$32K | – | 8395 |
|
|
2015
Q4 | $32K | Buy |
7,600
+1,300
| +21% | +$5.58K | ﹤0.01% | 7630 |
|
|
2015
Q3 | $26K | Sell |
6,300
-24,600
| -80% | -$155K | ﹤0.01% | 8021 |
|
|
2015
Q2 | $252K | Buy |
30,900
+20,200
| +189% | +$168K | ﹤0.01% | 6008 |
|
|
2015
Q1 | $83K | Sell |
10,700
-5,800
| -35% | -$49.6K | ﹤0.01% | 6998 |
|
|
2014
Q4 | $193K | Buy |
16,500
+5,300
| +47% | +$63.3K | ﹤0.01% | 6018 |
|
|
2014
Q3 | $145K | Sell |
11,200
-2,800
| -20% | -$36.9K | ﹤0.01% | 6051 |
|
|
2014
Q2 | $213K | Buy |
+14,000
| New | +$228K | ﹤0.01% | 5499 |
|
Citadel Advisors's CSLT Position: Q1 2022 in Review
Citadel Advisors sold out of CASTLIGHT HEALTH, INC. (CSLT) in Q1 2022, closing a stake of 213,778 shares — an estimated $329K sold.
Citadel Advisors first reported a position in CSLT in Q2 2014 and held it in 29 quarters. The position peaked at $1.36M in Q3 2015. 0 funds tracked by Wall St. Rank hold CSLT as of Q1 2022.
- Citadel Advisors reported no remaining CASTLIGHT HEALTH, INC. position as of Q1 2022 after selling out during the quarter.
- Citadel Advisors sold 213,778 CASTLIGHT HEALTH, INC. shares in Q1 2022, an estimated $329K.
- Citadel Advisors first reported a position in CASTLIGHT HEALTH, INC. in Q2 2014 and held it in 29 quarters.
- Citadel Advisors's CASTLIGHT HEALTH, INC. position peaked at $1.36M in Q3 2015.
- 0 funds tracked by Wall St. Rank held CASTLIGHT HEALTH, INC. as of Q1 2022.
Based on Citadel Advisors's 13F filing for Q1 2022, filed 16 May 2022.